SEARCH

SEARCH BY CITATION

References

  • Appenzeller, S., Schirmacher, A., Halfter, H., Baumer, S., Pendziwiat, M., Timmerman, V., De Jonghe, P., Fekete, K., Stogbauer, F., Ludemann, P., Hund, M., Quabius, E.S., Ringelstein, E.B. & Kuhlenbaumer, G. (2010) Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene. Am J Hum Genet 86, 8387.
  • Arnaud-Lopez, L., Usala, G., Ceresini, G. et al. (2008) Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 82, 12701280.
  • Athos, J., Impey, S., Pineda, V.V., Chen, X. & Storm, D.R. (2002) Hippocampal CRE-mediated gene expression is required for contextual memory formation. Nat Neurosci 5, 11191120.
  • Barad, M., Bourtchouladze, R., Winder, D.G., Golan, H. & Kandel, E. (1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 95, 1502015025.
  • Bender, A.T. & Beavo, J.A. (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58, 488520.
  • Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G. & Silva, A.J. (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 5968.
  • Bruchas, M.R., Land, B.B., Lemos, J.C. & Chavkin, C. (2009) CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One 4, e8528.
  • Clapcote, S.J., Lipina, T.V., Millar, J.K., Mackie, S., Christie, S., Ogawa, F., Lerch, J.P., Trimble, K., Uchiyama, M., Sakuraba, Y., Kaneda, H., Shiroishi, T., Houslay, M.D., Henkelman, R.M., Sled, J.G., Gondo, Y., Porteous, D.J. & Roder, J.C. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54, 387402.
  • Conti, M. & Beavo, J. (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76, 481511.
  • Dov, A., Abramovitch, E., Warwar, N. & Nesher, R. (2008) Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose. Endocrinology 149, 741748.
  • Favilla, C., Abel, T. & Kelly, M.P. (2008) Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J Neurosci 28, 1395213956.
  • Ferretti, V., Roullet, P., Sargolini, F., Rinaldi, A., Perri, V., Del Fabbro, M., Costantini, V.J., Annese, V., Scesa, G., De Stefano, M.E., Oliverio, A. & Mele, A. (2010) Ventral striatal plasticity and spatial memory. Proc Natl Acad Sci U S A 107, 79457950.
  • Fisher, D.A., Smith, J.F., Pillar, J.S., St Denis, S.H. & Cheng, J.B. (1998) Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 246, 570577.
  • Giampa, C., Laurenti, D., Anzilotti, S., Bernardi, G., Menniti, F.S. & Fusco, F.R. (2010) Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One 5, e13417.
  • Heaslip, R.J. & Evans, D.Y. (1995) Emetic, central nervous system, and pulmonary activities of rolipram in the dog. Eur J Pharmacol 286, 281290.
  • Horvath, A., Giatzakis, C., Tsang, K., Greene, E., Osorio, P., Boikos, S., Libe, R., Patronas, Y., Robinson-White, A., Remmers, E., Bertherat, J., Nesterova, M. & Stratakis, C.A. (2008) A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16, 12451253.
  • Imaizumi, M., Miyazaki, S. & Onodera, K. (1994) Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20–1724, in a light/dark test in mice. Methods Find Exp Clin Pharmacol 16, 717721.
  • Lakics, V., Karran, E.H. & Boess, F.G. (2010) Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59, 367374.
  • Levy, I., Horvath, A., Azevedo, M., de Alexandre, R.B. & Stratakis, C.A. (2011) Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment. Curr Opin Pharmacol 11, 689697.
  • Li, Y.F., Cheng, Y.F., Huang, Y., Conti, M., Wilson, S.P., O'Donnell, J.M. & Zhang, H.T. (2011) Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci 31, 172183.
  • Li, Y.F., Huang, Y., Amsdell, S.L., Xiao, L., O'Donnell, J.M. & Zhang, H.T. (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34, 24042419.
  • Lister, R.G. (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92, 180185.
  • Nishi, A., Kuroiwa, M., Miller, D.B., O'Callaghan, J.P., Bateup, H.S., Shuto, T., Sotogaku, N., Fukuda, T., Heintz, N., Greengard, P. & Snyder, G.L. (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 28, 1046010471.
  • Offermanns, S. (2001) In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. Oncogene 20, 16351642.
  • Perez-Torres, S., Cortes, R., Tolnay, M., Probst, A., Palacios, J.M. & Mengod, G. (2003) Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 182, 322334.
  • Phillips, R.G. & LeDoux, J.E. (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106, 274285.
  • Piccart, E., Gantois, I., Laeremans, A., de Hoogt, R., Meert, T., Vanhoof, G., Arckens, L. & D'Hooge, R. (2011) Impaired appetitively as well as aversively motivated behaviors and learning in PDE10A-deficient mice suggest a role for striatal signaling in evaluative salience attribution. Neurobiol Learn Mem 95, 260269.
  • Poser, S. & Storm, D.R. (2001) Role of Ca2 + −stimulated adenylyl cyclases in LTP and memory formation. Int J Dev Neurosci 19, 387394.
  • Rolls, E.T. & Kesner, R.P. (2006) A computational theory of hippocampal function, and empirical tests of the theory. Prog Neurobiol 79, 148.
  • Rutten, K., Misner, D.L., Works, M., Blokland, A., Novak, T.J., Santarelli, L. & Wallace, T.L. (2008) Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice. Eur J Neurosci 28, 625632.
  • Shiflett, M.W. & Balleine, B.W. (2011) Molecular substrates of action control in cortico-striatal circuits. Prog Neurobiol 95, 113.
  • Silvestre, J.S., Fernandez, A.G. & Palacios, J.M. (1999) Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. J Psychopharmacol 13, 274277.
  • Soderling, S.H., Bayuga, S.J. & Beavo, J.A. (1998) Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci U S A 95, 89918996.
  • Sweatt, J.D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76, 110.
  • Tsai, L.C., Shimizu-Albergine, M. & Beavo, J.A. (2011) The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland. Mol Pharmacol 79, 639648.
  • Vasta, V., Shimizu-Albergine, M. & Beavo, J.A. (2006) Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A. Proc Natl Acad Sci U S A 103, 1992519930.
  • Xu, Y., Zhang, H.T. & O'Donnell, J.M. (2011) Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Handb Exp Pharmacol 204, 447485.
  • Zweifel, L.S., Fadok, J.P., Argilli, E., Garelick, M.G., Jones, G.L., Dickerson, T.M., Allen, J.M., Mizumori, S.J., Bonci, A. & Palmiter, R.D. (2011) Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci 14, 620626.